BRNS

Barinthus Biotherapeutics
BRNS

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$4
456% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Yi Chen
0% 1-yr BRNS win rate
17 Nov ‘25 1 month ago